OHERZIO

Serial Number 98349198
731

Registration Progress

Application Filed
Jan 9, 2024
Under Examination
Aug 20, 2024
Approved for Publication
Jun 25, 2024
Published for Opposition
Jun 25, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Feb 20, 2026 188 days

Trademark Image

OHERZIO

Basic Information

Serial Number
98349198
Filing Date
January 9, 2024
Published for Opposition
June 25, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Aug 12, 2025
Application
Pending
Classes
005

Rights Holder

BioNTech SE

99
Address
An der Goldgrube 12
Mainz 55131
DE

Ownership History

BioNTech SE

Original Applicant
99
Mainz DE

BioNTech SE

Owner at Publication
99
Mainz DE

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

Next Deadline
188 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
February 20, 2026
Extension Available
Until August 20, 2025

Application History

16 events
Date Code Type Description Documents
Aug 13, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 12, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 12, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 12, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 11, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 11, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 20, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 25, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 25, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 5, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 21, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 20, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 28, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of cancer

Classification

International Classes
005